Joint Stock Company Grindeks is an international, vertically integrated pharmaceutical company. The main fields of action are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anti-cancer and diabetes medicines.
View Top Employees from GrindeksWebsite | http://www.grindeks.com |
Revenue | $508 million |
Employees | 370 (231 on RocketReach) |
Founded | 1946 |
Address | Krustpils Street 53, Riga, Riga LV 1057, LV |
Phone | +371 67 083 500 |
Fax | +371 67 083 505 |
Industry | Manufacturing, Pharmaceutical Manufacturing, Manufacturing General, Medical, Health Care, Pharmaceutical |
Web Rank | 1 Million |
Keywords | Healthcare, Pharmaceutical, Generic Drugs, Active Pharmaceutical Ingredients, Cardiovascular Services, Diabetes Care, Pharmaceutical Research |
Competitors | ESTEVE, Laurus Labs Limited, Lek Pharmaceuticals d.d., Orion Corporation, Siegfried Holding AG |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Grindeks employee's phone or email?
The Grindeks annual revenue was $508 million in 2024.
Elena Kovaleva is the Head of Marketing of Grindeks.
231 people are employed at Grindeks.
Grindeks is based in Riga, Riga.
The NAICS codes for Grindeks are [325, 32541, 3254, 32].
The SIC codes for Grindeks are [283, 28].